Concepts (60)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proto-Oncogene Proteins c-ret | 5 | 2023 | 20 | 2.220 |
Why?
|
| Lung Neoplasms | 5 | 2023 | 360 | 2.090 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2023 | 165 | 1.660 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2021 | 25 | 1.180 |
Why?
|
| Piperidines | 2 | 2019 | 48 | 1.120 |
Why?
|
| Antineoplastic Agents | 3 | 2023 | 686 | 0.990 |
Why?
|
| Thyroid Neoplasms | 2 | 2020 | 39 | 0.790 |
Why?
|
| Receptor, trkC | 1 | 2021 | 3 | 0.690 |
Why?
|
| Pyrimidines | 2 | 2020 | 128 | 0.670 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 105 | 0.610 |
Why?
|
| Quinazolines | 1 | 2019 | 32 | 0.600 |
Why?
|
| Drug Resistance | 1 | 2018 | 42 | 0.570 |
Why?
|
| Indoles | 1 | 2019 | 110 | 0.560 |
Why?
|
| Mutation | 2 | 2020 | 867 | 0.560 |
Why?
|
| Mutant Proteins | 1 | 2018 | 26 | 0.560 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2018 | 15 | 0.550 |
Why?
|
| Leukemia | 1 | 2018 | 30 | 0.550 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2017 | 2 | 0.530 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2017 | 6 | 0.530 |
Why?
|
| Alternative Splicing | 1 | 2017 | 48 | 0.520 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 472 | 0.420 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 300 | 0.410 |
Why?
|
| Pyrazoles | 2 | 2021 | 79 | 0.320 |
Why?
|
| Pyridines | 2 | 2021 | 108 | 0.320 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 1350 | 0.310 |
Why?
|
| Humans | 8 | 2023 | 28851 | 0.280 |
Why?
|
| Neoplasms | 1 | 2017 | 874 | 0.270 |
Why?
|
| Aurora Kinase A | 1 | 2023 | 3 | 0.200 |
Why?
|
| Aurora Kinase B | 1 | 2023 | 13 | 0.200 |
Why?
|
| Neoplasm, Residual | 1 | 2023 | 32 | 0.200 |
Why?
|
| MAP Kinase Signaling System | 1 | 2023 | 95 | 0.190 |
Why?
|
| Animals | 3 | 2019 | 10684 | 0.150 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 46 | 0.150 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 132 | 0.150 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2019 | 45 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 1 | 2019 | 284 | 0.140 |
Why?
|
| Crystallography, X-Ray | 1 | 2019 | 222 | 0.140 |
Why?
|
| Binding Sites | 1 | 2019 | 355 | 0.140 |
Why?
|
| Allosteric Regulation | 1 | 2018 | 22 | 0.140 |
Why?
|
| Mice | 2 | 2019 | 4802 | 0.140 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 416 | 0.140 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 170 | 0.140 |
Why?
|
| Mutation, Missense | 1 | 2018 | 71 | 0.140 |
Why?
|
| Gene Order | 1 | 2016 | 10 | 0.130 |
Why?
|
| Pyridazines | 1 | 2016 | 8 | 0.130 |
Why?
|
| Survival Analysis | 1 | 2017 | 288 | 0.120 |
Why?
|
| Mitosis | 1 | 2017 | 115 | 0.120 |
Why?
|
| X-Ray Microtomography | 1 | 2016 | 33 | 0.120 |
Why?
|
| Transgenes | 1 | 2016 | 63 | 0.120 |
Why?
|
| Imidazoles | 1 | 2016 | 63 | 0.120 |
Why?
|
| Genetic Vectors | 1 | 2016 | 118 | 0.120 |
Why?
|
| Biopsy | 1 | 2016 | 208 | 0.120 |
Why?
|
| Amino Acid Sequence | 1 | 2017 | 697 | 0.120 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 120 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 465 | 0.110 |
Why?
|
| RNA, Messenger | 1 | 2017 | 668 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 513 | 0.110 |
Why?
|
| Gene Expression | 1 | 2016 | 417 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 841 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 1507 | 0.080 |
Why?
|